L. Waetjen, M.D.

L. Elaine Waetjen, M.D.



Obstetrics and Gynecology


Obstetrics and Gynecology


  • Professor
To see if L. Elaine Waetjen is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).

Lawrence J. Ellison Ambulatory Care Center

4860 Y St., Suite 2500
Sacramento, CA 95817
Driving Directions

Primary Phone:

Additional Phone Numbers

Physician Referrals: 800-4-UCDAVIS (800-482-3284)

Clinical Interests

Dr. Waetjen is a general gynecologist who also specializes in caring for women with problems that most commonly affect mid-life and older women: menopausal symptoms, vulvar/vaginal symptoms, fibroids, and vulvar/cervix dysplasia.  

Dr. Waetjen studies menopause with a special interest in the epidemiology of gynecological conditions that affect mid-life and older women. Her diverse research includes investigating treatment seeking behavior in women with urinary incontinence and the relationship between the vaginal microbiome and vulvar, vaginal, and urinary health.  

She also works with the University of California Fibroid Network to study the outcomes of new and standard treatment options for fibroids.  

Additionally, Dr. Waetjen dedicates time to caring for underserved women.  She sees patients regularly at the Sacramento County Jail and has experience in international women’s health, traveling with medical teams to Uganda, Niger, Jamaica, and Tanzania.


Obstetrics and Gynecology

Center/Program Affiliation

Center for Healthcare Policy and Research


M.D., Northwestern University, Chicago, Illinois, 1995

B.A., UC Santa Barbara, Santa Barbara, California, 1986

B.A., UC Santa Cruz, Santa Cruz, California, 1991


University of Pittsburgh, Magee-Women's Hospital, Pittsburgh, Pennsylvania, 1996-1999


UC San Francisco, San Francisco, California, 1999-2001

Board Certifications

American Board of Obstetrics and Gynecology, 2001

Professional Memberships

American College of Obstetrics and Gynecology

North American Menopause Society

Honors and Awards

B.A. with Highest Honors, UC Santa Cruz, 1991

B.A. with Honors, UC Santa Barbara, 1986

Select Recent Publications

Thurston RC, Sowers MR, Sternfeld B, Gold EB, Bromberger J, Chang Y, Joffe H, Crandall CJ, Waetjen LE, Matthews KA, Gains in Body Fat and Vasomotor Symptom Reporting Over the Menopausal Transition: The Study of Women's Health Across the Nation, American Journal of Epidemiology 2009; 170:766-774.

Waetjen LE, Ye J, Feng WY, Johnson WO, Greendale GA, Sampselle CM, Sternfield B, Harlow S, Gold EB. Association between Menopausal Transition and the Development of Urinary Incontinence. Obstetrics and Gynecology 2009;114(5):989-98.

Waetjen LE, Management of Stress Urinary Incontinence, Menopause Management, May/June 2008, Vol 17(3): 14-25.

Waetjen LE, Feng WY, Ye J, Johnson WO, Greendale GA, Sampselle CM, Sternfield B, Harlow S, Gold EB, Factors Associated with Worsening and Improving Urinary Incontinence Across the Menopausal Transition, Obstetrics and Gynecology, March 2008, Vol 111 (3): 667-677.

Smith L, Waetjen LE, Paik C, Xing G, Trends in the Safety of Inpatient Hysterectomy for Benign Conditions in California 1991-2004, Obstetrics and Gynecology, September 2008, Vol 112(3): 553-61.

Waetjen LE, Liao S, Johnson WO, Sampselle CM, Sternfield B, Harlow SD, Gold EB. Factors associated with prevalent and incident urinary incontinence in a cohort of mid-life women: A longitudinal analysis of data. Study of Women’s Health Across the Nation. American Journal of Epidemiology, 165(3):309-18, February 2007.

Paik CK, Waetjen LE, Xing G, Dai J, Sweet RL. Hospitalizations for pelvic inflammatory disease and tuboovarian abscess. Obstetrics and Gynecology, 107(3):611-616, March 2006.

Waetjen LE, Dwyer PL. Estrogen therapy and urinary incontinence: What is the evidence and what do we tell our patients? International Urogynecology Journal, 17(5):541-5, October 2006. Epub.

Steinauer JE, Waetjen LE, Subak LL, Lin F, Vittinghoff E, Brown JS, Hulley SB, Grady D. Postmenopausal hormone therapy: Does it cause incontinence?, Obstetrics and Gynecology, 105(5):940-945, November 2005.

Waetjen LE, Brown JS, Vittinghoff E, Ensrud K, Pinkerton J, Wallace R, Macer J, Grady D. The effect of ultralow-dose transdermal estradiol on urinary incontinence in postmenopausal women. Obstetrics and Gynecology, 105(5):946-952, November 2005.

Waetjen LE, Modleska K, Blackwell T, Vittinghoff E, Brown JS, Cummings SR. Effects of raloxifene on urinary incontinence: Results from a randomized, controlled trial of raloxifene. Obstetrics and Gynecology, 103(2):261-266, February 2004.

Waetjen LE, Subak LL, Shen H, Lin F, Wang TH, Vittinghoff E, Brown JS. Stress urinary incontinence surgery in the United States. Obstetrics and Gynecology, 101(4):671-676, April 2003.

Brown JS, Waetjen LE, Subak LL, Thom DH, Van den Eeden S, Vittinghoff E. Pelvic organ prolapse surgery in the United States, 1997. American Journal of Obstetrics and Gynecology, 186(4):712-716, April 2002.

Subak LL, Waetjen LE, Vittinghoff E, Thom DH, Van den Eeden S, Brown JS. Cost of pelvic organ prolapse surgery in the United States. Obstetrics and Gynecology, 98(4):646-651, October 2001.